What this is
Single filing record
This page shows the rows from one Form 4 filing as reported to the SEC.
Blue Collar Picks
Big buy
$3.6M open-market purchase by David Efraim Rosen, 10% Owner at Heron Therapeutics,inc. /DE/, filed August 12, 2025. Learn more
What this is
This page shows the rows from one Form 4 filing as reported to the SEC.
Why it matters
The original SEC document is the source record. Always verify before drawing conclusions.
How to read it
Insider activity carries more weight from senior officers, large dollar values, and clustered timing.
Stacked feeds
David Efraim Rosen · 10% Owner at Heron Therapeutics,inc. /DE/
David Efraim Rosen bought $3.6M of HRTX (Heron Therapeutics,inc. /DE/).
Insider purchase
David Efraim Rosen, a 10% beneficial owner, reported a $3.6M open-market purchase equal to 4.5% of HRTX's market cap.
David Efraim Rosen (10% Owner) bought 2,387,225 shares of HRTX, Heron Therapeutics,inc. /DE/, Healthcare ($79.0M market cap), at $1.50 per share on August 8, 2025 for a total of $3.6M (4.5% of the market cap).
David Efraim Rosen
10% Owner
Permalink https://bluecollarpicks.com/insider-trading/HRTX/buy/40780
Market context
Last enriched June 21, 2026 at 5:57 AM EDT.
Filings
Latest visible filing loading.
Public Form 4 filings, normalized for cleaner scanning. What do these codes mean?
| Ticker | Type & Role | Value | |
|---|---|---|---|
Exercise and Hold CFO | Not reported | ||
Exercise and Hold Officer | Not reported | ||
Exercise and Hold Officer | Not reported | ||
Exercise and Hold Officer | Not reported | ||
Exercise and Hold CEO | Not reported | ||
Exercise and Hold CFO | Not reported | ||
Exercise and Hold CEO | Not reported | ||
Exercise and Hold Officer | Not reported | ||
Exercise and Hold CFO | Not reported | ||
Exercise and Hold CEO | Not reported | ||
Exercise and Hold CEO | Not reported | ||
Grant CEO | $0 | ||
Grant CEO | $0 | ||
Grant Director | $0 | ||
Grant Director | $0 | ||
Grant CFO | $0 | ||
Grant CFO | $0 | ||
Grant Director | $0 | ||
Grant Director | $0 | ||
Grant Officer | $0 | ||
Grant Officer | $0 | ||
Grant Director | $0 | ||
Grant Officer | $0 | ||
Grant Officer | $0 | ||
Grant Director | $0 | ||
Exercise and Hold CFO | Not reported | ||
Exercise and Hold Officer | Not reported | ||
Exercise and Hold CEO | Not reported | ||
Exercise and Hold CFO | Not reported | ||
Exercise and Hold Officer | Not reported | ||
Exercise and Hold CEO | Not reported | ||
Exercise and Hold Officer | Not reported | ||
Exercise and Hold CFO | Not reported | ||
Exercise and Hold CEO | Not reported | ||
Exercise and Hold CEO | Not reported | ||
Exercise and Hold Officer | Not reported | ||
Exercise and Hold CFO | Not reported | ||
Cluster Buy Director | $2.6M | ||
Cluster Buy 10% Owner | $3.6M | ||
| This filing | Cluster Buy 10% Owner | $3.6M | |
Selected filing
Select a row to inspect the filing.
Cluster detail
Ticker context
Recent insider activity for this company.
Insider detail
Recent transactions grouped by reporting owner.
Filters
Weekly recap
Start with the free weekly recap. Upgrade later if you want the paid daily brief.
Free weekly recap. No login required. Unsubscribe any time.
Method Public Form 4 filings, normalized for cleaner scanning. Filtered rows stay available in All Form 4 Filings and ticker history. Which view should I use? →
Paid research tools
Join the waitlist for founding-member access to CSV exports, saved screens, and premium download tools when they open.